Načítá se...
Gastrointestinal cancers: current biomarkers in esophageal and gastric adenocarcinoma
Esophageal and gastric adenocarcinomas are frequently diagnosed at an advanced stage and have a dismal prognosis. Even in patients with potentially curative cancer, nearly 50% will develop recurrent disease despite aggressive treatments. A number of biomarkers currently guide treatment decisions for...
Uloženo v:
| Vydáno v: | Transl Gastroenterol Hepatol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
AME Publishing Company
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7530320/ https://ncbi.nlm.nih.gov/pubmed/33073050 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tgh.2020.01.08 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|